Literature DB >> 12595900

DOK4 and DOK5: new Dok-related genes expressed in human T cells.

C Favre1, A Gérard, E Clauzier, P Pontarotti, D Olive, J A Nunès.   

Abstract

Dok proteins are adapter proteins involved in signal transduction. Several intracellular proteins expressed in lymphocytes meet the criteria of membrane-associated adapter proteins such as members of the Dok family. To understand the role and the formation of multiprotein networks involving Dok proteins in T lymphocytes, we search for potential additional members of this family. Here, we describe the two new human dok-related genes DOK4 and DOK5 and present data showing the expression of DOK4 and DOK5 genes in T cells. These genes are the orthologues of mouse Dok4 and Dok5 genes. Based on analysis of phylogenetic trees and exon/intron structure of Dok family members, DOK4 and DOK5 define a subfamily within dok genes distinct from DOK1, DOK2 and DOK3. So, Dok-4 and Dok-5 molecules constitute a new group of adapter proteins in T cells, requiring further functional analysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595900     DOI: 10.1038/sj.gene.6363891

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  15 in total

1.  Detection of homo- or hetero-association of Doks by fluorescence resonance energy transfer in living cells.

Authors:  Feng Zhang; Guo Fu; Chen Wang; Li Cao; Hua-Yan Yang; Gui-Ying Wang; Yi-Zhang Chen; Cheng He
Journal:  Mol Imaging Biol       Date:  2008-11-25       Impact factor: 3.488

2.  Evaluation of DOK5 as a susceptibility gene for type 2 diabetes and obesity in North Indian population.

Authors:  Rubina Tabassum; Anubha Mahajan; Ganesh Chauhan; Om Prakash Dwivedi; Saurabh Ghosh; Nikhil Tandon; Dwaipayan Bharadwaj
Journal:  BMC Med Genet       Date:  2010-02-27       Impact factor: 2.103

3.  Mutational analysis of the DOK2 haploinsufficient tumor suppressor gene in chronic myelomonocytic leukemia (CMML).

Authors:  E Coppin; V Gelsi-Boyer; X Morelli; N Cervera; A Murati; P P Pandolfi; D Birnbaum; J A Nunès
Journal:  Leukemia       Date:  2014-09-25       Impact factor: 11.528

4.  Dok-4 is a novel negative regulator of T cell activation.

Authors:  Audrey Gérard; Marguerite Ghiotto; Camille Fos; Geoffrey Guittard; Daniel Compagno; Anne Galy; Serge Lemay; Daniel Olive; Jacques A Nunès
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

5.  A genome-wide association study of amygdala activation in youths with and without bipolar disorder.

Authors:  Xinmin Liu; Nirmala Akula; Martha Skup; Melissa A Brotman; Ellen Leibenluft; Francis J McMahon
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-01       Impact factor: 8.829

Review 6.  Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis.

Authors:  João Agostinho Machado-Neto; Bruna Alves Fenerich; Ana Paula Nunes Rodrigues Alves; Jaqueline Cristina Fernandes; Renata Scopim-Ribeiro; Juan Luiz Coelho-Silva; Fabiola Traina
Journal:  Clinics (Sao Paulo)       Date:  2018-10-11       Impact factor: 2.365

Review 7.  Emerging Roles of Downstream of Kinase 3 in Cell Signaling.

Authors:  Jia Tong Loh; Joey Kay Hui Teo; Hong-Hwa Lim; Kong-Peng Lam
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

8.  Expression and function of the insulin receptor substrate proteins in cancer.

Authors:  Katerina Mardilovich; Shannon L Pankratz; Leslie M Shaw
Journal:  Cell Commun Signal       Date:  2009-06-17       Impact factor: 5.712

9.  An Emerging Role for PI5P in T Cell Biology.

Authors:  Jacques A Nunès; Geoffrey Guittard
Journal:  Front Immunol       Date:  2013-04-02       Impact factor: 7.561

10.  Genome-wide scans identify known and novel regions associated with prolificacy and reproduction traits in a sub-Saharan African indigenous sheep (Ovis aries).

Authors:  Asrat Tera Dolebo; Negar Khayatzadeh; Aberra Melesse; David Wragg; Mourad Rekik; Aynalem Haile; Barbara Rischkowsky; Max F Rothschild; Joram M Mwacharo
Journal:  Mamm Genome       Date:  2019-11-22       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.